about the author

Josh Sullivan

josh@endpointsnews.com

author articles

Mod­er­na tur­bocharges its sup­ply chain, up­ping com­mit­ment to 3B dos­es per year for a fu­ture where boost­ers are like­ly

5 years ago
Outsourcing
Coronavirus

BeiGene's late stage tri­al shows promis­ing num­bers; Am­gen to study so­tora­sib dosage af­ter FDA rec­om­men­da­tion

5 years ago
News Briefing

News brief­ing: Af­ter lengthy odyssey, Rea­ta is fi­nal­ly ready for its close­up; MIT's Hock­field takes board seat at ...

5 years ago
News Briefing

Covid-19 roundup: Gilead aims remde­sivir to­ward help­ing In­dia out­break; Mer­ck pairs with 5 In­di­an gener­ics ...

5 years ago
Coronavirus

Bio­gen re­vers­es course on com­pas­sion­ate use for ALS drug tofersen with plans to open pro­gram in Ju­ly

5 years ago
Pharma
Cell/Gene Tx

The Car­lyle Group shells out $435M for con­trol­ling stake in vac­cine, gene ther­a­py ser­vices com­pa­ny

5 years ago
Deals

Sanofi lands 3rd Covid-19 vac­cine man­u­fac­tur­ing part­ner as it works to push for­ward its own jab

5 years ago
Coronavirus
Manufacturing

J&J's Trem­fya scores 5-year pso­ri­a­sis win in AAD da­ta dump; Roche, Re­gen­eron drugs among lat­est to earn EU ad­vi­so­ry ...

5 years ago
News Briefing

April show­ers bring more biotechs to Nas­daq, as Rain and Im­pel bump 2021's to­tal raise above $6B

5 years ago
Financing

JP Gabriel watched from the bleach­ers as the pan­dem­ic raged. Now head of sup­ply chain at Ocu­gen, he's ready to bat

5 years ago
R&D
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: Mary­land looks to grow biotech ca­pac­i­ty with $400M check; Rus­sia lands sec­ond Sput­nik ...

5 years ago
Coronavirus
Manufacturing

LLS backs 5 new can­cer drug projects with up to $50M; Trodelvy con­tin­ues to im­press with more TNBC da­ta

5 years ago
News Briefing

In a sup­ply chain short­age workaround, Aus­trali­a's Vic­to­ria state aims to build its own mR­NA fa­cil­i­ty

5 years ago
Coronavirus
Manufacturing

In­vi­tae sets up shop in North Car­oli­na as part of plan to rapid­ly ex­pand its ge­net­ic test­ing man­u­fac­tur­ing

5 years ago
Manufacturing

Bris­tol My­ers finds a home for 1st EU cell ther­a­py site, clear­ing land near Am­s­ter­dam air­port for easy lo­gis­tics

5 years ago
Cell/Gene Tx
Manufacturing

Bris­tol My­ers adds on at Cam­bridge Cross­ing, set­tling in even fur­ther in bustling Boston-area biotech hub

5 years ago
Pharma

Eli Lil­ly plots NDA as sec­ond JAK study backs baric­i­tinib for alope­cia area­ta; Al­ny­lam heads to FDA af­ter full ...

5 years ago
News Briefing

Am­gen's promis­ing gas­tric can­cer drug makes good on Five Prime po­ten­tial with FDA's break­through nod

5 years ago
FDA+

FDA lays the ham­mer on Emer­gen­t's Bal­ti­more plant af­ter J&J de­ba­cle, halt­ing all pro­duc­tion in un­usu­al move

5 years ago
R&D
Manufacturing

Covid-19 roundup: Sup­ply chain short­ages lead to half the Mod­er­na dos­es de­liv­ered to Cana­da; J&J shots paused out of ...

5 years ago
Coronavirus

Avro­bio is us­ing 'pod­s' to cre­ate gene ther­a­pies, and it be­lieves the ap­proach could change the game al­to­geth­er

5 years ago
R&D
Manufacturing

FDA blasts Colom­bian drug man­u­fac­tur­er in warn­ing let­ter for not prop­er­ly ad­dress­ing API flaws

5 years ago
R&D
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: Mod­er­na eyes Nexus' Wis­con­sin plant for vac­cine boost; Catal­ent wraps up plant ...

5 years ago
Coronavirus
Manufacturing

Alchemab bags fresh round of in­vestors for tar­get-ag­nos­tic an­ti­body de­vel­op­ment for Hunt­ing­ton's, Covid-19

5 years ago
Financing
R&D
First page Previous page 242526272829 Next page Last page
A service from the Financial Times